These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 16140285

  • 1. Transplants of neurosphere cell suspensions from aged mice are functional in the mouse model of Parkinson's.
    Meissner KK, Kirkham DL, Doering LC.
    Brain Res; 2005 Sep 28; 1057(1-2):105-12. PubMed ID: 16140285
    [Abstract] [Full Text] [Related]

  • 2. Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease.
    Aponso PM, Faull RL, Connor B.
    Neuroscience; 2008 Feb 19; 151(4):1142-53. PubMed ID: 18201835
    [Abstract] [Full Text] [Related]

  • 3. Effects of engrafted neural stem cells derived from GFP transgenic mice in Parkinson's diseases rats.
    Wei P, Liu J, Zhou HL, Han ZT, Wu QY, Pang JX, Liu S, Wang TH.
    Neurosci Lett; 2007 May 23; 419(1):49-54. PubMed ID: 17420097
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice.
    Iancu R, Mohapel P, Brundin P, Paul G.
    Behav Brain Res; 2005 Jul 01; 162(1):1-10. PubMed ID: 15922062
    [Abstract] [Full Text] [Related]

  • 6. Transplantation of bone marrow stromal cells containing the neurturin gene in rat model of Parkinson's disease.
    Ye M, Wang XJ, Zhang YH, Lu GQ, Liang L, Xu JY, Chen SD.
    Brain Res; 2007 Apr 20; 1142():206-16. PubMed ID: 17336273
    [Abstract] [Full Text] [Related]

  • 7. Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease.
    Yasuhara T, Shingo T, Kobayashi K, Takeuchi A, Yano A, Muraoka K, Matsui T, Miyoshi Y, Hamada H, Date I.
    Eur J Neurosci; 2004 Mar 20; 19(6):1494-504. PubMed ID: 15066146
    [Abstract] [Full Text] [Related]

  • 8. Neurorescue effects of VEGF on a rat model of Parkinson's disease.
    Yasuhara T, Shingo T, Muraoka K, Kameda M, Agari T, Wen Ji Y, Hayase H, Hamada H, Borlongan CV, Date I.
    Brain Res; 2005 Aug 16; 1053(1-2):10-8. PubMed ID: 16045899
    [Abstract] [Full Text] [Related]

  • 9. Anatomical and functional reconstruction of the nigrostriatal pathway by intranigral transplants.
    Gaillard A, Decressac M, Frappé I, Fernagut PO, Prestoz L, Besnard S, Jaber M.
    Neurobiol Dis; 2009 Sep 16; 35(3):477-88. PubMed ID: 19616502
    [Abstract] [Full Text] [Related]

  • 10. Combined treatment of neurotrophin-3 gene and neural stem cells is ameliorative to behavior recovery of Parkinson's disease rat model.
    Gu S, Huang H, Bi J, Yao Y, Wen T.
    Brain Res; 2009 Feb 27; 1257():1-9. PubMed ID: 19111525
    [Abstract] [Full Text] [Related]

  • 11. Behavioral/neurophysiological investigation of effects of combining a quinolinic acid entopeduncular lesion with a fetal mesencephalic tissue transplant in striatum of the 6-OHDA hemilesioned rat.
    Olds ME, Jacques DB, Kpoyov O.
    Synapse; 2003 Jul 27; 49(1):1-11. PubMed ID: 12710010
    [Abstract] [Full Text] [Related]

  • 12. Functional effect of FGF2- and FGF8-expanded ventral mesencephalic precursor cells in a rat model of Parkinson's disease.
    Jensen P, Pedersen EG, Zimmer J, Widmer HR, Meyer M.
    Brain Res; 2008 Jul 07; 1218():13-20. PubMed ID: 18513704
    [Abstract] [Full Text] [Related]

  • 13. Adjunctive use of the non-ionic surfactant Poloxamer 188 improves fetal dopaminergic cell survival and reinnervation in a neural transplantation strategy for Parkinson's disease.
    Quinn M, Mukhida K, Sadi D, Hong M, Mendez I.
    Eur J Neurosci; 2008 Jan 07; 27(1):43-52. PubMed ID: 18093176
    [Abstract] [Full Text] [Related]

  • 14. Behavioral changes in unilaterally 6-hydroxy-dopamine lesioned rats after transplantation of differentiated mouse embryonic stem cells without morphological integration.
    Baier PC, Schindehütte J, Thinyane K, Flügge G, Fuchs E, Mansouri A, Paulus W, Gruss P, Trenkwalder C.
    Stem Cells; 2004 Jan 07; 22(3):396-404. PubMed ID: 15153616
    [Abstract] [Full Text] [Related]

  • 15. Generation of graftable dopaminergic neuron progenitors from mouse ES cells by a combination of coculture and neurosphere methods.
    Morizane A, Takahashi J, Shinoyama M, Ideguchi M, Takagi Y, Fukuda H, Koyanagi M, Sasai Y, Hashimoto N.
    J Neurosci Res; 2006 May 01; 83(6):1015-27. PubMed ID: 16493682
    [Abstract] [Full Text] [Related]

  • 16. Dopaminergic neuroprotection by neurturin-expressing c17.2 neural stem cells in a rat model of Parkinson's disease.
    Liu WG, Lu GQ, Li B, Chen SD.
    Parkinsonism Relat Disord; 2007 Mar 01; 13(2):77-88. PubMed ID: 16963309
    [Abstract] [Full Text] [Related]

  • 17. Long-term survival of human central nervous system progenitor cells transplanted into a rat model of Parkinson's disease.
    Svendsen CN, Caldwell MA, Shen J, ter Borg MG, Rosser AE, Tyers P, Karmiol S, Dunnett SB.
    Exp Neurol; 1997 Nov 01; 148(1):135-46. PubMed ID: 9398456
    [Abstract] [Full Text] [Related]

  • 18. Uptake of 6-[18F]fluoro-L-dopa and [18F]CFT reflect nigral neuronal loss in a rat model of Parkinson's disease.
    Forsback S, Niemi R, Marjamäki P, Eskola O, Bergman J, Grönroos T, Haaparanta M, Haapalinna A, Rinne J, Solin O.
    Synapse; 2004 Feb 01; 51(2):119-27. PubMed ID: 14618679
    [Abstract] [Full Text] [Related]

  • 19. Dopaminergic differentiation of grafted GFP transgenic neuroepithelial stem cells in the brain of a rat model of Parkinson's disease.
    Sun J, Gao Q, Miller K, Wang X, Wang J, Liu W, Bao L, Zhang J, Zhang L, Poon WS, Gao Y.
    Neurosci Lett; 2007 Jun 08; 420(1):23-8. PubMed ID: 17499438
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.